Related Experiment Video
Updated: Aug 2, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clinical Features and Blood Indicators for Severity and Prognosis in COVID-19 Patients
Insights
Clinical manifestations and blood indicators in COVID-19 patients were analyzed. Critical illness in Coronavirus disease 2019 (COVID-19) may be indicated by advanced age and specific blood markers, including white blood cell (WBC) and C-reactive protein (CRP).
Area of Science:
- Infectious Diseases
- Hematology
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) presents with diverse clinical manifestations.
- Understanding key clinical and hematological indicators is crucial for managing COVID-19 patients.
Purpose of the Study:
- To analyze clinical signs and blood indicators in COVID-19 patients.
- To identify predictors of critical illness and mortality in COVID-19.
Main Methods:
- Retrospective analysis of 61 hospitalized COVID-19 patients.
- Comparison of clinical and laboratory data between non-critical and critical groups, and between survivors and non-survivors.
Main Results:
- Critical COVID-19 patients exhibited higher age, fever rates, and elevated levels of white blood cell (WBC), basophils, lactate dehydrogenase (LDH), C-reactive protein (CRP), high-sensitivity troponin, pro-brain natriuretic peptide (pro-BNP), prothrombin time (PT), and D-dimer.
- Lower levels of lymphocytes, eosinophils, and albumin were observed in critical patients.
- WBC, basophils, and LDH were significantly higher in the non-surviving subgroup compared to survivors.
Conclusions:
- Advanced age, high fever, and specific hematological markers (elevated WBC, basophils, CRP, LDH, troponin, pro-BNP, D-dimer; decreased lymphocytes, eosinophils, albumin) may predict critical COVID-19.
- These indicators can aid in early identification and management of severe cases.
- Hematological parameters offer valuable insights into COVID-19 severity and prognosis.
Background:
This study aimed to analyze the clinical manifestations and blood indicators to deepen the understanding of Coronavirus disease 2019 (COVID-19).
Methods:
COVID-19 patients admitted to C10 West Ward, Tongji Hospital in Wuhan City ("West Ward") between January 31 and March 28, 2020, were retrospectively analyzed.
Results:
A total of 61 COVID-19 patients were hospitalized, wherein the non-critical Group had 30 cases, while the critical group had 31 (including 14 survivors and 17 deaths). Age, the proportion of fever cases, white blood cell (WBC), basophils, red blood cell (RBC), hemoglobin, lactate dehydrogenase (LDH), C-reactive protein (CRP), high-sensitivity troponin, pro-BNP (brain natriuretic peptide), prothrombin time (PT), and D-dimer were higher in the critical group while lymphocytes, eosinophils, albumin were lower compared with those of the non-critical group (all p < 0.05). WBC (p = 0.008), basophils (p = 0.034), and LDH (p = 0.005) of the death subgroup climbed remarkably in comparison with those of the survival subgroup.
Conclusions:
Advanced age, high fever, increases in indicators such as WBC, basophils, CRP, LDH, high-sensitivity troponin, pro-BNP, and D-dimer, and decreases in indicators, including lymphocytes, eosinophils, and albumin, might forebode a critical condition.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests
Pneumonia III: Complications and Assessment
Coronary Artery Disease III: Clinical Manifestations
Pericarditis II: Clinical Features and Diagnostic Tests

